Buchumschlag

Molecular subtypes of intrahepatic cholangiocarcinoma

Intrahepatic cholangiocarcinoma (iCCA) presents in two clinically distinct subtypes: large duct (LD-iCCA) and small duct (SD-iCCA). These subtypes exhibit significant molecular, genetic, and histopathological differences that impact patient prognosis and treatment responsiveness. This review advocat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: De Santis, Alessandro (VerfasserIn) , Zhu, Lei (VerfasserIn) , Tao, Jianxin (VerfasserIn) , Reißfelder, Christoph (VerfasserIn) , Schölch, Sebastian (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: August 2025
In: Trends in molecular medicine
Year: 2025, Jahrgang: 31, Heft: 8, Pages: 755-769
ISSN:1471-499X
DOI:10.1016/j.molmed.2025.01.008
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.molmed.2025.01.008
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S1471491425000085
Volltext
Verfasserangaben:Alessandro De Santis, Lei Zhu, Jianxin Tao, Christoph Reißfelder, and Sebastian Schölch
Beschreibung
Zusammenfassung:Intrahepatic cholangiocarcinoma (iCCA) presents in two clinically distinct subtypes: large duct (LD-iCCA) and small duct (SD-iCCA). These subtypes exhibit significant molecular, genetic, and histopathological differences that impact patient prognosis and treatment responsiveness. This review advocates for a subtype-specific approach to iCCA research and clinical management, including tailored therapeutic strategies that consider distinct genetic profiles and tumor microenvironments. Current therapeutic approaches hold promise, yet efficacy varies by subtype. Additionally, subtype-specific molecular diagnostics, including DNA methylation-based classifiers and transcriptomic sequencing, have shown potential in refining iCCA subclassification, thereby guiding precision medicine efforts. This article outlines existing clinical trials, key research trajectories, and future directions for developing more effective subtype-adapted therapies for iCCA.
Beschreibung:Online verfügbar: 15. Februar 2025, Artikelversion: 13. August 2025
Gesehen am 01.12.2025
Beschreibung:Online Resource
ISSN:1471-499X
DOI:10.1016/j.molmed.2025.01.008

Ähnliche Einträge